Tompkins Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$263K Sell
4,558
-200
-4% -$11.5K 0.02% 177
2026
Q1
$289K Buy
4,758
+66
+1% +$3.85K 0.02% 161
2025
Q4
$253K Sell
4,692
-1,016
-18% -$48.9K 0.02% 175
2025
Q3
$257K Hold
5,708
0.02% 168
2025
Q2
$264K Sell
5,708
-3,443
-38% -$169K 0.02% 159
2025
Q1
$558K Buy
9,151
+225
+3% +$13.1K 0.05% 123
2024
Q4
$505K Sell
8,926
-160
-2% -$8.94K 0.05% 119
2024
Q3
$470K Sell
9,086
-1,057
-10% -$49.6K 0.05% 127
2024
Q2
$421K Sell
10,143
-2,021
-17% -$90.4K 0.04% 141
2024
Q1
$660K Buy
12,164
+325
+3% +$16.6K 0.07% 115
2023
Q4
$607K Buy
11,839
+1,358
+13% +$71.3K 0.07% 115
2023
Q3
$608K Sell
10,481
-1,167
-10% -$71.5K 0.1% 103
2023
Q2
$745K Sell
11,648
-450
-4% -$30.2K 0.12% 98
2023
Q1
$839K Sell
12,098
-2,977
-20% -$210K 0.14% 88
2022
Q4
$1.08M Buy
15,075
+213
+1% +$16.1K 0.17% 81
2022
Q3
$1.06M Hold
14,862
0.18% 81
2022
Q2
$1.15M Sell
14,862
-400
-3% -$30.5K 0.18% 79
2022
Q1
$1.11M Buy
15,262
+4,641
+44% +$312K 0.16% 84
2021
Q4
$662K Buy
10,621
+820
+8% +$48.1K 0.12% 85
2021
Q3
$580K Buy
+9,801
New +$645K 0.11% 89
2021
Q1
$654K Sell
10,356
-241
-2% -$15K 0.11% 88
2020
Q4
$657K Sell
10,597
-1,601
-13% -$98.4K 0.12% 87
2020
Q3
$735K Sell
12,198
-809
-6% -$48.7K 0.14% 86
2020
Q2
$765K Sell
13,007
-530
-4% -$31.7K 0.16% 83
2020
Q1
$755K Sell
13,537
-91
-0.7% -$5.56K 0.17% 79
2019
Q4
$875K Buy
13,628
+9,099
+201% +$521K 0.16% 88
2019
Q3
$229K Buy
4,529
+100
+2% +$4.7K 0.05% 148
2019
Q2
$201K Sell
4,429
-1,208
-21% -$56.3K 0.04% 153
2019
Q1
$269K Sell
5,637
-144
-2% -$7.17K 0.05% 146
2018
Q4
$300K Buy
5,781
+200
+4% +$10.7K 0.07% 140
2018
Q3
$347K Sell
5,581
-1
-0% -$59 0.07% 140
2018
Q2
$309K Hold
5,582
0.07% 147
2018
Q1
$353K Sell
5,582
-517
-8% -$33.3K 0.08% 139
2017
Q4
$374K Buy
6,099
+1,146
+23% +$71.7K 0.09% 129
2017
Q3
$315K Sell
4,953
-200
-4% -$11.7K 0.07% 136
2017
Q2
$287K Buy
5,153
+200
+4% +$10.9K 0.07% 135
2017
Q1
$270K Sell
4,953
-397
-7% -$21.8K 0.07% 134
2016
Q4
$313K Hold
5,350
0.08% 125
2016
Q3
$288K Sell
5,350
-400
-7% -$25.7K 0.08% 128
2016
Q2
$423K Buy
5,750
+967
+20% +$68.3K 0.13% 113
2016
Q1
$306K Sell
4,783
-787
-14% -$49.6K 0.1% 130
2015
Q4
$383K Buy
5,570
+144
+3% +$9.52K 0.12% 128
2015
Q3
$321K Sell
5,426
-723
-12% -$45.9K 0.1% 132
2015
Q2
$409K Buy
6,149
+219
+4% +$14.4K 0.11% 124
2015
Q1
$382K Hold
5,930
0.1% 131
2014
Q4
$350K Sell
5,930
-174
-3% -$9.81K 0.09% 134
2014
Q3
$312K Sell
6,104
-240
-4% -$12K 0.08% 138
2014
Q2
$308K Sell
6,344
-1,001
-14% -$49.3K 0.08% 142
2014
Q1
$382K Buy
7,345
+535
+8% +$28.5K 0.1% 128
2013
Q4
$362K Sell
6,810
-5,517
-45% -$281K 0.09% 128
2013
Q3
$570K Buy
12,327
+860
+7% +$37.8K 0.16% 105
2013
Q2
$512K Buy
+11,467
New +$498K 0.15% 107

Other funds holding BMY

Tompkins Financial's BMY Position: Q2 2026 in Review

Tompkins Financial reduced its Bristol-Myers Squibb (BMY) stake by 4.2% in Q2 2026, selling an estimated $11.5K and leaving 4,558 shares worth $263K. The position accounts for 0.02% of the portfolio, ranked #177.

Tompkins Financial first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.15M in Q2 2022. 851 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Tompkins Financial held 4,558 shares of Bristol-Myers Squibb worth $263K as of Q2 2026.
  • Tompkins Financial sold 200 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.5K.
  • Bristol-Myers Squibb made up 0.02% of Tompkins Financial's portfolio in Q2 2026, its #177 holding.
  • Tompkins Financial first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Tompkins Financial's Bristol-Myers Squibb position peaked at $1.15M in Q2 2022.
  • 851 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Tompkins Financial's 13F filing for Q2 2026, filed 15 Jul 2026.